B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 9.58 USD 0.31%
Market Cap: 777.4m USD
Have any thoughts about
Bioventus Inc?
Write Note

Bioventus Inc
Goodwill

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bioventus Inc
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioventus Inc
NASDAQ:BVS
Goodwill
$7.5m
CAGR 3-Years
-47%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Goodwill
$616.2m
CAGR 3-Years
10%
CAGR 5-Years
24%
CAGR 10-Years
6%
ICU Medical Inc
NASDAQ:ICUI
Goodwill
$1.5B
CAGR 3-Years
256%
CAGR 5-Years
166%
CAGR 10-Years
99%
Align Technology Inc
NASDAQ:ALGN
Goodwill
$471.5m
CAGR 3-Years
3%
CAGR 5-Years
49%
CAGR 10-Years
23%
Lantheus Holdings Inc
NASDAQ:LNTH
Goodwill
$61.2m
CAGR 3-Years
0%
CAGR 5-Years
31%
CAGR 10-Years
15%
Merit Medical Systems Inc
NASDAQ:MMSI
Goodwill
$399.4m
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
8%
No Stocks Found

Bioventus Inc
Glance View

Market Cap
777.2m USD
Industry
Health Care

Bioventus, Inc. global medical technology company which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. The company is headquartered in Durham, North Carolina and currently employs 1,200 full-time employees. The company went IPO on 2021-02-11. The firm is focused on developing and commercializing clinically and minimally invasive treatments that engage and enhance the body’s natural healing process. The Company’s portfolio of products includes OA joint pain treatment and joint preservation, bone graft substitutes and minimally invasive fracture treatment. The OA joint pain treatment and joint preservation is focused on orthopedics. Its bone graft substitutes (BGSs) offers portfolio of products including human tissue allografts and synthetics. Its BGS products can be used in conjunction with any orthopedic fixation and spinal fusion implant. They are designed to improve bone fusion rates following spinal fusion and other orthopedic surgeries and reduce the need for using the patient’s own bone.

BVS Intrinsic Value
11.53 USD
Undervaluation 17%
Intrinsic Value
Price
B

See Also

What is Bioventus Inc's Goodwill?
Goodwill
7.5m USD

Based on the financial report for Dec 31, 2023, Bioventus Inc's Goodwill amounts to 7.5m USD.

What is Bioventus Inc's Goodwill growth rate?
Goodwill CAGR 5Y
-32%

Over the last year, the Goodwill growth was -46%. The average annual Goodwill growth rates for Bioventus Inc have been -47% over the past three years , -32% over the past five years .

Back to Top